[1] Akamatsu, N., Sugawara, Y. and Hashimoto, D. (2011) Surgical Strategy for Bile Duct Cancer: Advances and Current Limitations. World Journal of Clinical Oncology, 2, 94.
http://dx.doi.org/10.5306/wjco.v2.i2.94
[2] Aljiffry, M., Walsh, M.J. and Molinari, M. (2009) Advances in Diagnosis, Treatment and Palliation of Cholangiocarcinoma: 1990-2009. World Journal of Gastroenterology, 15, 4240-4262.
http://dx.doi.org/10.3748/wjg.15.4240
[3] Andersen, J.R., Sorensen, S.M., Kruse, A., Rokkjaer, M. and Matzen, P. (1989) Randomised Trial of Endoscopic Endoprosthesis versus Operative Bypass in Malignant Obstructive Jaundice. Gut, 30, 1132-1135.
http://dx.doi.org/10.1136/gut.30.8.1132
[4] Goenka, M.K. and Goenka, U. (2014) Palliation: Hilar Cholangiocarcinoma. World Journal of Hepatology, 6, 559-569.
[5] Moss, A.C., Morris, E., Leyden, J. and MacMathuna, P. (2007) Do the Benefits of Metal Stents Justify the Costs? A Systematic Review and Meta-Analysis of Trials Comparing Endoscopic Stents for Malignant Biliary Obstruction. European Journal of Gastroenterology & Hepatology, 19, 1119-1124.
http://dx.doi.org/10.1097/MEG.0b013e3282f16206
[6] Schmassmann, A., von Gunten, E., Knuchel, J., Scheurer, U., Fehr, H.F. and Halter, F. (1996) Wallstents versus Plastic Stents in Malignant Biliary Obstruction: Effects of Stent Patency of the First and Second Stent on Patient Compliance and Survival. The American Journal of Gastroenterology, 91, 654-659.
[7] Yoon, W.J., Ryu, J.K., Yang, K.Y., Paik, W.H., Lee, J.K., Woo, S.M., Park, J.K., Kim, Y.T. and Yoon, Y.B. (2009) A Comparison of Metal and Plastic Stents for the Relief of Jaundice in Unresectable Malignant Biliary Obstruction in Korea: An Emphasis on Cost-Effectiveness in a Country with a low ERCP Cost. Gastrointestinal Endoscopy, 70, 284-289.
http://dx.doi.org/10.1016/j.gie.2008.12.241
[8] Raju, R.P., Jaganmohan, S.R., Ross, W.A., Davila, M.L., Javle, M., Raju, G.S. and Lee, J.H. (2011) Optimum Palliation of Inoperable Hilar Cholangiocarcinoma: Comparative Assessment of the Efficacy of Plastic and Self-Expanding Metal Stents. Digestive Diseases and Sciences, 56, 1557-1564.
http://dx.doi.org/10.1007/s10620-010-1550-5
[9] Loew, B.J., Howell, D.A., Sanders, M.K., Desilets, D.J., Kortan, P.P., May, G.R., Shah, R.J., Chen, Y.K., Parsons, W.G., Hawes, R.H., Cotton, P.B., Slivka, A.A., Ahmad, J., Lehman, G.A., Sherman, S., Neuhaus, H. and Schumacher, B.M. (2009) Comparative Performance of Uncoated, Self-Expanding Metal Biliary Stents of Different Designs in 2 Diameters: Final Results of an International Multicenter, Randomized, Controlled Trial. Gastrointestinal Endoscopy, 70, 445-453.
http://dx.doi.org/10.1016/j.gie.2008.11.018
[10] Isayama, H., Komatsu, Y., Tsujino, T., Sasahira, N., Hirano, K., Toda, N., Nakai, Y., Yamamoto, N., Tada, M., Yoshida, H., Shiratori, Y., Kawabe, T. and Omata, M. (2004) A Prospective Randomised Study of “Covered” versus “Uncovered” Diamond Stents for the Management of Distal Malignant Biliary Obstruction. Gut, 53, 729-734.
http://dx.doi.org/10.1136/gut.2003.018945
[11] Zoepf, T., Jakobs, R., Arnold, J.C., Apel, D. and Riemann, J.F. (2005) Palliation of Nonresectable Bile Duct Cancer: Improved Survival after Photodynamic Therapy. The American Journal of Gastroenterology, 100, 2426-2430.
http://dx.doi.org/10.1111/j.1572-0241.2005.00318.x
[12] Ortner, M.E., Caca, K., Berr, F., Liebetruth, J., Mansmann, U., Huster, D., Voderholzer, W., Schachschal, G., Mossner, J. and Lochs, H. (2003) Successful Photodynamic Therapy for Nonresectable Cholangiocarcinoma: A Randomized Prospective Study. Gastroenterology, 125, 1355-1363.
http://dx.doi.org/10.1016/j.gastro.2003.07.015
[13] Tal, A.O., Vermehren, J., Friedrich-Rust, M., Bojunga, J., Sarrazin, C., Zeuzem, S., Trojan, J. and Albert, J.G. (2014) Intraductal Endoscopic Radiofrequency Ablation for the Treatment of Hilar Non-Resectable Malignant Bile Duct Obstruction. World Journal of Gastrointestinal Endoscopy, 6, 13-19.
http://dx.doi.org/10.4253/wjge.v6.i1.13
[14] Alis, H., Sengoz, C., Gonenc, M., Kalayci, M.U. and Kocatas, A. (2013) Endobiliary Radiofrequency Ablation for Malignant Biliary Obstruction. Hepatobiliary & Pancreatic Diseases International, 12, 423-427.
http://dx.doi.org/10.1016/S1499-3872(13)60066-1
[15] Strand, D.S., Cosgrove, N.D., Patrie, J.T., Cox, D.G., Bauer, T.W., Adams, R.B., Mann, J.A., Sauer, B.G., Shami, V.M. and Wang, A.Y. (2014) ERCP-Directed Radiofrequency Ablation and Photodynamic Therapy Are Associated with Comparable Survival in the Treatment of Unresectable Cholangiocarcinoma. Gastrointestinal Endoscopy, 80, 794-804.
http://dx.doi.org/10.1016/j.gie.2014.02.1030
[16] Rustagi, T. and Jamidar, P.A. (2014) Intraductal Radiofrequency Ablation for Management of Malignant Biliary Obstruction. Digestive Diseases and Sciences, 59, 2635-2641.
http://dx.doi.org/10.1007/s10620-014-3237-9
[17] Steel, A.W., Postgate, A.J., Khorsandi, S., Nicholls, J., Jiao, L., Vlavianos, P., Habib, N. and Westaby, D. (2011) Endoscopically Applied Radiofrequency Ablation Appears to Be Safe in the Treatment of Malignant Biliary Obstruction. Gastrointestinal Endoscopy, 73, 149-153.
http://dx.doi.org/10.1016/j.gie.2010.09.031
[18] Wadsworth, C.A., Westaby, D. and Khan, S.A. (2013) Endoscopic Radiofrequency Ablation for Cholangiocarcinoma. Current Opinion in Gastroenterology, 29, 305-311.
http://dx.doi.org/10.1097/MOG.0b013e32835faacc
[19] Figueroa-Barojas, P., Bakhru, M.R., Habib, N.A., Ellen, K., Millman, J., Jamal-Kabani, A., Gaidhane, M. and Kahaleh, M. (2013) Safety and Efficacy of Radiofrequency Ablation in the Management of Unresectable Bile Duct and Pancreatic Cancer: A Novel Palliation Technique. Journal of Oncology, 2013, 1-5.
http://dx.doi.org/10.1155/2013/910897
[20] National Comprehensive Cancer Network (2010) NCCN Clinical Practice Guidelines in Oncology: Hepatiobiliary Cancers, V.1.2010.
http://www.nccn.org/professionals/physician_gls/PDF/hepatobiliary.pdf
[21] Dindo, D., Demartines, N. and Clavien, P.A. (2004) Classification of Surgical Complications: A New Proposal with Evaluation in a Cohort of 6336 Patients and Results of a Survey. Annals of Surgery, 240, 205-213.
http://dx.doi.org/10.1097/01.sla.0000133083.54934.ae
[22] Goldberg, S.N., Hahn, P.F., Tanabe, K.K., Mueller, P.R., Schima, W., Athanasoulis, C.A., Compton, C.C., Solbiati, L. and Gazelle, G.S. (1998) Percutaneous Radiofrequency Tissue Ablation: Does Perfusion-Mediated Tissue Cooling Limit Coagulation Necrosis? Journal of Vascular and Interventional Radiology, 9, 101-111.
http://dx.doi.org/10.1016/S1051-0443(98)70491-9
[23] Pai, M., Valek, V., Tomas, A., Doros, A., Quaretti, P., Golfieri, R., Mosconi, C. and Habib, N. (2014) Percutaneous Intraductal Radiofrequency Ablation for Clearance of Occluded Metal Stent in Malignant Biliary Obstruction: Feasibility and Early Results. CardioVascular and Interventional Radiology, 37, 235-240.
http://dx.doi.org/10.1007/s00270-013-0688-x
[24] Valle, J., Wasan, H., Palmer, D.H., Cunningham, D., Anthoney, A., Maraveyas, A., Madhusudan, S., Iveson, T., Hughes, S., Pereira, S.P., Roughto, M. and Bridgewater, J. (2010) Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer. New England Journal of Medicine, 362, 1273-1281.
http://dx.doi.org/10.1056/NEJMoa0908721